Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 840 clinical trials
A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

/metastatic HCC with Child-Pugh B7 liver disease who have received no prior systemic therapy.

  • 0 views
  • 10 Apr, 2021
  • 1 location
TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer

would preclude safe delivery of TheraSphere treatment and place the patient at undue risk. Required Lab Parameters AST or ALT <5 times ULN For HCC: Bilirubin 2.0 mg/dl (unless segmental

  • 0 views
  • 23 Jan, 2021
  • 1 location
Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma

The subjects of primary hepatocellular carcinoma diagnosed pathologically or clinically will be grouped according to the size, location, number and function of the liver, and respectively

  • 0 views
  • 22 Jan, 2021
  • 1 location
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma

The purpose of this study is to evaluate the clinical efficacy of thymopentin on the prevention of the recurrence and metastasis of small HCC after resection.

metastasis
cancer
  • 5 views
  • 07 Nov, 2020
  • 1 location
Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion

hepatocellular carcinoma with intrahepatic vessels invasion.

hepatectomy
TACE
chemoembolization
ethanol injection
percutaneous ethanol injection
  • 2 views
  • 07 Nov, 2020
  • 1 location
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

The purpose of this study is to evaluate the influence of sirolimus on outcome after OLT for HCC exceeding Milan criteria.

vascular invasion
  • 1 views
  • 07 Nov, 2020
  • 1 location
Genetic Polymorphisms of TNF- Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease

The prognosis of Hepatitis B virus (HBV)infection varies from minimal progressive liver disease to cirrhosis or hepatocellular carcinoma (HCC).Both viral and host genetic factors

tumor necrosis factor-alpha
tumor necrosis factor
cirrhosis
hepatocellular carcinoma
liver disease
  • 0 views
  • 07 Nov, 2020
  • 1 location
Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)

To evaluate Quality of Life (QoL) score of MS-20 versus placebo in advanced HCC patients using European Organization for Research and Treatment of Cancer (EORTC) QLQ C-30 questionnaire.

systemic chemotherapy
biliary tract cancer
radiofrequency ablation
ct scan
hepatoma
  • 1 views
  • 07 Nov, 2020
  • 1 location
Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma

Background Hepatocellular carcinoma, a malignant tumor of liver is one of the most common cancers worldwide. All India Institute Of Medical Sciences (AIIMS) being a tertiary care hospital

cancer
chemoembolization
unresectable hepatocellular carcinoma
cirrhosis
TACE
  • 30 views
  • 07 Nov, 2020
  • 1 location
A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer

Primary: To compare the efficacy of TACE and TAIE. Secondary: To compare the side effects of TACE and TAIE. The outcome measurements include survival benefit and tumour regression induced by the two therapies.

cancer
liver cancer
chemoembolization
transcatheter arterial chemoembolisation
interferon
  • 1 views
  • 07 Nov, 2020
  • 1 location